Farther Finance Advisors LLC Buys 163 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Farther Finance Advisors LLC boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 4.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,506 shares of the financial services provider’s stock after acquiring an additional 163 shares during the period. Farther Finance Advisors LLC’s holdings in iShares Biotechnology ETF were worth $480,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of IBB. Future Financial Wealth Managment LLC bought a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at about $27,000. Bbjs Financial Advisors LLC bought a new position in iShares Biotechnology ETF during the second quarter worth about $31,000. Pacifica Partners Inc. lifted its position in iShares Biotechnology ETF by 118.2% during the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after purchasing an additional 130 shares during the period. Crewe Advisors LLC increased its stake in iShares Biotechnology ETF by 42.9% in the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 78 shares during the last quarter. Finally, YHB Investment Advisors Inc. acquired a new stake in iShares Biotechnology ETF in the first quarter valued at about $37,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.7 %

iShares Biotechnology ETF stock opened at $145.66 on Wednesday. The stock has a 50-day moving average price of $143.72 and a two-hundred day moving average price of $137.84. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $150.17.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.